ALK Fusion-positive Solid or CNS Tumors research hub

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors

This study looks at a new medicine called alectinib for children and teenagers with specific cancers that haven't responded to other treatments. Doctors want to see if it's safe, how it works in the body, and if it can help treat these cancers.